AUB ScholarWorks

Mediators of the inhibitory effect of FTY720 phosphate, an analogue of sphingosine one phosphate, on hepatic Na⁺-K⁺ ATPase -

Show simple item record

dc.contributor.author Al-Alam, Nadine Mikhael,
dc.date.accessioned 2017-08-30T13:57:02Z
dc.date.available 2017-08-30T13:57:02Z
dc.date.issued 2014
dc.date.submitted 2014
dc.identifier.other b18335809
dc.identifier.uri http://hdl.handle.net/10938/10538
dc.description Thesis. M.S. American University of Beirut. Department of Biology, 2014. T:6202
dc.description Advisor : Dr. Sawsan Kuraydiyyah, Professor, Biology ; Members of Committee : Dr. Khouzama Knio, Professor, Biology ; Dr Colin Smith, Associate Professor, Biology.
dc.description Includes bibliographical references (leaves 56-71)
dc.description.abstract An inhibitory effect of sphingosine -1- phosphate (S1P) on hepatic Na⁺-K⁺ ATPase was previously demonstrated. This work is an attempt to delineate the signaling pathway involved using its agonist FTY720P (FTY720P). HepG2 cells were used as a model and the activity of the Na⁺-K⁺ ATPase was assayed by measuring the amount of inorganic phosphate liberated in presence and absence of ouabain, a specific inhibitor of the ATPase. FTY720P (7.5 nM, 15min) significantly inhibited the Na⁺-K⁺ATPase. This effect disappeared completely in presence of JTE-013, a specific blocker of S1P2 receptors. The inhibition was similarly abrogated by calphostin, indomethacin, RpcAMP, PTIO, an NF-κB inhibitor, and PD98059, respective inhibitors of protein kinase C (PKC), cyclooxygenases, protein kinase A (PKA), nitric oxide synthase (NOS), NF-κB, and extracellular signal-regulated kinase (ERK1-2). Treatment with prostaglandin E₂ (PGE₂) or selective activators of these enzymes mimicked the effect of FTY720P which was shown by western blot analysis to increase IκB degradation. PGE2 was found to act via its EP2 receptors, and its effect was still manifested in the presence of calphostin, and the NF-κB inhibitor but disappeared completely in presence of inhibitors of PKA, NOS,and ERK, suggesting that PGE2 is downstream of PKC and NF-κB and upstream of PKA, NO, and ERK. The effect of PMA, a PKC activator, was completely abolished by NF-κB inhibitor indicating that NF-κB is downstream of PKC and upstream of PGE₂. Furthermore, western blot analysis showed phosphorylation of ERK by dibutyrylcyclic adenosine monophosphate, a PKA activator. This phosphorylation did not appear in presence of PTIO indicating that PKA is upstream of NO. It was concluded that FTY 720-P activates PKC via S1P2 receptors leading to NF-κB activation and PGE2 generation. PGE₂ acts through its EP2 receptor and activates PKA which in turn activates NOS leading to NO
dc.format.extent 1 online resource (xiv, 71 leaves) : color illustrations ; 30cm
dc.language.iso eng
dc.relation.ispartof Theses, Dissertations, and Projects
dc.subject.classification T:006202
dc.subject.lcsh Sodium-potassium ATPase.
dc.subject.lcsh Prostaglandins.
dc.subject.lcsh Sphingosine.
dc.subject.lcsh Liver cells.
dc.subject.lcsh Sphingolipids.
dc.subject.lcsh Nitric oxide.
dc.title Mediators of the inhibitory effect of FTY720 phosphate, an analogue of sphingosine one phosphate, on hepatic Na⁺-K⁺ ATPase -
dc.type Thesis
dc.contributor.department Faculty of Arts and Sciences.
dc.contributor.department Department of Biology,
dc.contributor.institution American University of Beirut.


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account